| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00077 | 1 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.00069 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |